Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia

Digestive Diseases and Sciences

Volumn 41, Issue 7, 1996, Pages 1319-1326

  Peleg, Ika I ^a   Lubin, Michael F ^b   Cotsonis, George A ^b   Clark, W Scott ^b   Wilcox, C Mel ^b  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b NONE

Author keywords

adenoma; chemoprevention; colon cancer; nonsteroidal antiinflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; DICLOFENAC; IBUPROFEN; INDOMETACIN; ISPAGULA; MECLOFENAMIC ACID; MULTIVITAMIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; SALSALATE; SULINDAC;

ADENOMA; ADULT; AGED; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; AGED; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CALCIUM; CHEMOPREVENTION; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PSYLLIUM; RISK FACTORS; VITAMINS;

EID: 0030017494     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088554     Document Type: Article

References (45)

1. Boring CC, Squires TS, Tong T, Montgomery S: Cancer statistics, 1994. CA 44:27-43, 1994
2. Potter JD, Slattery ML, Bostick RM, Gapstur SM: Colon cancer: A review of the epidemiology. Epidemiol Rev 15:499-545, 1993
3. Zimmerman J: Does dietary calcium supplementation reduce the risk of colon cancer? Nutr Rev 51:109-112, 1993
4. Dwyer J: Dietary fiber and colorectal cancer risk. Nutr Rev 51:147-155, 1993
5. Ausman LM: Fiber and colon cancer: Does the current evidence justify a preventive policy? Nutr Rev 51:57-63, 1993
6. Baron JA, Greenburg ER: Could aspirin really prevent colon cancer. N Engl J Med 325:1644-1646, 1991
7. Farmer KC, Goulston K, Mcrae F: Aspirin and non-steroidal anti-inflammatory drug in the chemoprevention of colorectal cancer. Med J Aust 159:649-650, 1993
8. Greenburg ER, Baron JA: Prospects for preventing colorectal cancer death. J Natl Cancer Inst 85:1182-1183, 1993
9. Paganini-Hill A: Aspirin and colorectal cancer. Br Med J 307:278-279, 1993
10. Water-house DM, Brenner D: Aspirin, NSAIDS and risk reduction of colorectal cancer Arch Intern Med 154:366-367, 1994
11. Baron JA, Adami AO: A broad anticancer effect of aspirin? Epidemiology 5:133-134, 1994
12. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52:5575-5589, 1992
13. Earnest DJ, Hixson LJ, Alberts DS: Pirioxicam and other cyclooxygenase inhibitors: A potential for cancer chemoprevention. J Cell Biochem Suppl 161:156-166, 1992
14. Turner D, Berkel HJ: Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. Can Med Assoc J 149:595-602, 1993
15. Waddell WR: The effect of sulindac on colon polyps: Circumvention of a transformed phenotype - a hypothesis. J Surg Oncol 55:52-55, 1994
16. Kune GA, Kune S, Watson LF: Colorectal cancer risk, chronicillnesses, operations, and medications: Case-control results from the Melbourne colorectal cancer study. Cancer Res 48:4399-4404, 1988
17. Rosenburg L, Palmer RJ, Zauber AG, Warshauer ME, Stolley PD: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355-358, 1991
18. Peleg I, Maibach HT, Brown SH, Wilcox, CM: Aspirin and nonsteroidal antiinflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154:394-399, 1994
19. Suh O, Mettlin C, Petrelli NJ: Aspirin use, cancer and polyps of the large bowel. Cancer 72:1171-1177, 1993
20. Logan RFA, Little J, Hatwin PG, Hardcastle JD: Effect of aspirin and nonsteroidal anti-inflammatory drugs on the risk of colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br Med J 307:285-288, 1993
21. Greenburg ER, Baron JA, Freeman DH, Mandel JS, Haile R: Reduced risk of large bowel adenomas among aspirin users. J Natl Cancer Inst 85:912-916, 1993
22. Thun MJ, Nambroodiri MN, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596, 1991
23. Thun MJ, Calle EE, Nambroodiri MM, Heath CW Jr., et al: Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84:1491-1500, 1992
24. Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5:138-146, 1994
25. Paganini-Hill A, Chao A, Ross RK, Henderson BE: Aspirin use and chronic diseases: A cohort study in the elderly. Br Med J 299:1247-1250, 1989
26. Paganini-Hill A, Hsu G, Ross RK, Henderson BE: Aspirin use and incidence of large-bowel in a California retirement community. J Natl Cancer Inst 83:1182-1183, 1991 (letter)
27. Paganini-Hill A, Hsu G, Ross RK, Henderson BE: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 326:1290, 1992 (letter)
28. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH: Low-dose aspirin use and the incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85:1220-1224, 1993
29. Muscat JE, Stellman SD, Wynder EL: Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 74:1846-1857, 1994
30. Tempero MA: Progress in chemoprevention of gastrointestinal cancer. Curr Opin Oncol 3:719-726, 1991
31. Walker HK, Camp H, Brown S: The THERESA on-line medical record. Presentation to the Society of General Internal Medicine 14th Annual Meeting May 1, 1990
32. BMDP Statistical Software Inc. v. 1993, Los Angeles, California 90025
33. Bedenne L, Faivre J, Boutron MC, et al: Adenoma-carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remenants in a population-based series of large bowel cancer. Cancer 69:883-888, 1992
34. Horm JW, Asire AJ, Young AJ, Jr. Pollack ES: SEER program: Cancer incidence and mortality in the United States 1473-1981. NIH Publication 85-1873, Bethesda, Maryland 20205, National Cancer Institute
35. Smigel K: Aspirin's next conquest: Does it prevent colorectal cancer? J Natl Cancer Inst 86:166-168, 1994
36. Cairns J, Cohen L, Colton T, et al: Issues in the early termination of the aspirin component of the Physicians' Health Study. Ann Epidemiol 1:395-405, 1991
37. Physician's Desk Reference. Medical Economics Data 1992. p 1447
38. DuBois RN: Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenoma. Gastroenterology 108:A478, 1995
39. Hanif R, Pittas A, Feng Y, Koutsos MI, Shiff SJ, Staiano-Coico L, Rigas B: NSAIDs inhibit the cell growth of colon cancer cell lines by a prostaglandin independent pathway. Gastroenterology 108:A478, 1995
40. Waddell WR, Ganser GF, Cerise EJ, Loughry RW: Sulindac for polyposis of the colon. Am J Surg 157:175-179, 1989
41. Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM: Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 115:952-955, 1991
42. Giardiello FM, Hamilton SR, Krush AJ, et al: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316, 1993
43. Labayle D, Fischer D, Viehl P, Drouhin F, Pariente F, Bories C, Duhamel O, Trousset M, Attali P: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639, 1991
44. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM: Adenomatous lesions of the large bowel. Cancer 43:1847-1857, 1979
45. Eddy DM: Screening for colorectal cancer. Ann Intern Med 113:373-384, 1990